Avi Rubinov, Eytan Z Blumenthal, Itzchak Beiran. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAngiogenesis Inhibitors/administration & dosageAnti-Bacterial Agents/administration & dosageAntibodies, Monoclonal, Humanized/administration & dosageBartonella henselae/isolation & purificationBevacizumabCat-Scratch Disease/complicationsCat-Scratch Disease/drug therapyCat-Scratch Disease/microbiologyCat-Scratch Disease/physiopathologyDoxycycline/administration & dosageFluorescein Angiography/methodsHumansIntravitreal InjectionsMaleRetinal Vein Occlusion/diagnosisRetinal Vein Occlusion/drug therapyRetinal Vein Occlusion/etiologyRetinal Vein Occlusion/physiopathologyRifampin/administration & dosageTomography, Optical Coherence/methodsTreatment OutcomeVision Disorders/etiology
Substances： See more » Angiogenesis InhibitorsAnti-Bacterial AgentsAntibodies, Monoclonal, HumanizedBevacizumabDoxycyclineRifampin
Year: 2014 PMID： 25269350
Source DB: PubMed Journal: Isr Med Assoc J Impact factor: 0.892